Abstract
Osteoporosis is an important age-related disease; its largest incidence occurs in postmenopausal women. Social and economical consequences are considerable as it is frequent and leads to fractures, particularly of the hip and vertebrae. In the elderly, and particularly the very elderly, fracture morbidity leads to mortality as they may be complicated by pneumonia or venous thromboembolism due to immobilization. The disease is characterized by a progressive reduction of bone density, which not only includes demineralization but also structural rarification. Typical risk factors apart from female sex are
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chrischilles EA, Butler CD, Davis CS, Wallace RB (1991) A model of lifetime osteoporosis impact. Arch Intern Med 151:2026–2032
Donaldson MG, Cawthon PM, Lui LY et al (2010) Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation guidelines. J Bone Miner Res 25:1506–1511
Duque G, Mallet L, Roberts A, Gingrass S, Kremer R, Sainte-Marie LG, Kiel DP (2007) To treat or not to treat, that is the question: proceedings of the Quebec symposium for the treatment of osteoporosis in long-term care institutions, Saint- Hyacinthe, Quebec, November 5, 2004. J Am Med Dir Assoc 8(3 Suppl 2):e67–e73
Looker AC, Orwoll ES, Johnston CC Jr et al (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:1761–1768
Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) HORIZON Recurrent Fracture Trial. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809
National Osteoporosis Foundation (2002) America’s bone health: the state of osteoporosis and low bone mass in our nation. National Osteoporosis Foundation, Washington, DC
National Osteoporosis Foundation (2010) Clinician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC
U.S. Department of Health and Human Services (2004) Bone health and osteoporosis: a report of the surgeon general. U.S. Department of Health and Human Services, Office of the Surgeon General, Rockville
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Wehling, M. (2013). Osteoporosis. In: Wehling, M. (eds) Drug Therapy for the Elderly. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0912-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0912-0_12
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0911-3
Online ISBN: 978-3-7091-0912-0
eBook Packages: MedicineMedicine (R0)